California biotech Calibr and partner AbbVie have reported the first clinical data on a new CAR-T technology, which uses "switchable" cells that aim to eliminate the life-threatening side-effects ...
Subscribe to Technology Networks’ daily newsletter ... Common forms of cell therapy that use T cells—the immune system’s soldiers that fight infections and cancers—include chimeric antigen receptor T ...
Christopher Walken told The Wall Street Journal that his relationship with technology is nonexistent to the point that he doesn’t own a cell phone and only watches television via a satellite ...